Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYNERGY: Belimumab and Voclosporin in Proliferative Lupus Nephritis
NCT07225387Phase 4Recruiting
- Sponsor
- NephroNet
- Start
- Oct 2024
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of voclosporin in lupus nephritis (LN), sponsored by NephroNet. Started Oct 2024; status: recruiting.
02
Drugs
voclosporin
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT07225387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07225387.